SEC Comment Letter for Cyclerion Therapeutics, Inc. (CYCN) (CIK 0001755237) (KRSA) — Mar 14, 2019
Cyclerion Therapeutics, Inc. (CYCN) (CIK 0001755237)
Date: March 14, 2019 · CIK: 0001755237 · Accession: 0000000000-19-004815
AI Filing Summary & Sentiment
File numbers found in text: 001-38787
Letter
March 14, 2019 Mark Currie President Cyclerion Therapeutics, Inc. 301 Binney Street Cambridge, MA 02142 Re:Cyclerion Therapeutics, Inc. Registration Statement on Form 10-12B Filed on January 28, 2019 File No. 001-38787 Dear Dr. Currie: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Will Michener, Esq.
Show Raw Text
March 14, 2019
Mark Currie
President
Cyclerion Therapeutics, Inc.
301 Binney Street
Cambridge, MA 02142
Re:Cyclerion Therapeutics, Inc.
Registration Statement on Form 10-12B
Filed on January 28, 2019
File No. 001-38787
Dear Dr. Currie:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Will Michener, Esq.